In myotonic dystrophy type 1 (DM1), triplet repeat expansion in the 3′ untranslated region of dystrophia myotonica protein kinase (DMPK) causes the nuclear retention of mutant messenger RNA (mRNA). Although the DMPK gene locus positions precisely at the outer edge of a factor-rich SC-35 domain, the normal mRNA consistently accumulates within the domain, and this RNA is depleted upon transcriptional inhibition. In DM1, mutant transcripts detach from the gene but accumulate in granules that abut but do not enter SC-35 domains, suggesting that RNA entry into the domain is blocked. Despite their exclusion from these compartments, mutant transcripts are spliced. MBNL1 (muscleblind-like protein 1) is an alternative splicing factor that becomes highly concentrated with mutant RNA foci. Small interfering RNA–mediated knockdown of MBNL1 promotes the accumulation or entry of newly synthesized mutant transcripts in the SC-35 domain. Collectively, these data suggest that an initial step in the intranuclear path of some mRNAs is passage from the gene into an SC-35 domain and implicate these structures in postsplicing steps before export.
Skip Nav Destination
Article navigation
10 September 2007
Article|
September 10 2007
Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains
Kelly P. Smith,
Kelly P. Smith
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Search for other works by this author on:
Meg Byron,
Meg Byron
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Search for other works by this author on:
Carol Johnson,
Carol Johnson
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Search for other works by this author on:
Yigong Xing,
Yigong Xing
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Search for other works by this author on:
Jeanne B. Lawrence
Jeanne B. Lawrence
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Search for other works by this author on:
Kelly P. Smith
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Meg Byron
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Carol Johnson
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Yigong Xing
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Jeanne B. Lawrence
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
Correspondence to Jeanne B. Lawrence: [email protected]
Abbreviations used in this paper: DMPK, dystrophia myotonica protein kinase; hnRNP H, heterogeneous nuclear RNP H; HSMM, human skeletal muscle myoblast; MRG, mutant RNA granule.
Received:
June 07 2007
Accepted:
August 09 2007
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2007
J Cell Biol (2007) 178 (6): 951–964.
Article history
Received:
June 07 2007
Accepted:
August 09 2007
Citation
Kelly P. Smith, Meg Byron, Carol Johnson, Yigong Xing, Jeanne B. Lawrence; Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains . J Cell Biol 10 September 2007; 178 (6): 951–964. doi: https://doi.org/10.1083/jcb.200706048
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement